2016
DOI: 10.1021/acs.langmuir.6b00082
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of Sticholysin II-Induced Pore Formation by Lipid Bilayer Composition, Phase State, and Interfacial Properties

Abstract: Sticholysin II (StnII) is a pore-forming toxin that uses sphingomyelin (SM) as the recognition molecule in targeting membranes. After StnII monomers bind to SM, several toxin monomers act in concert to oligomerize into a functional pore. The regulation of StnII binding to SM, and the subsequent pore-formation process, is not fully understood. In this study, we examined how the biophysical properties of bilayers, originating from variations in the SM structure, from the presence of sterol species, or from the p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
46
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 21 publications
(52 citation statements)
references
References 49 publications
6
46
0
Order By: Relevance
“…In these experiments, the fluorescent dye conjugated to the toxin colocalized with the DOPC domains ( dark areas in Fig. 2 C ) indicating that the toxin preferentially binds to the fluid phase domains than to the gel domains, a result consistent with the observations made with monolayers of FraC and leakage assays of sticholysin II (40). Based on these results, membranes composed of DOPC were selected for structural studies analyzing the conformation of FraC bound to membranes in a non-lytic scenario.…”
Section: Resultssupporting
confidence: 86%
“…In these experiments, the fluorescent dye conjugated to the toxin colocalized with the DOPC domains ( dark areas in Fig. 2 C ) indicating that the toxin preferentially binds to the fluid phase domains than to the gel domains, a result consistent with the observations made with monolayers of FraC and leakage assays of sticholysin II (40). Based on these results, membranes composed of DOPC were selected for structural studies analyzing the conformation of FraC bound to membranes in a non-lytic scenario.…”
Section: Resultssupporting
confidence: 86%
“…PFPs present different mechanisms to target their objective. The most common ones are the interaction of a specific lipid, like cholesterol (Chol) [53,[60][61][62][63][64][65][66][67][68][69][70][71][72][73] or sphingomyelin (SM) [12,25,26,44,69,[74][75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90][91], or recognition of a specific membrane protein receptor [32,[92][93][94][95][96]. It is common to find collections of highly prey-specific toxins as part of multigene families resulting in an extended range of different targets [97].…”
Section: Pore-forming Proteinsmentioning
confidence: 99%
“…It has been largely accepted that actinoporins do not need a protein receptor to exert their toxicity, but instead require sphingomyelin as a specific lipidic receptor [16,17,26,27,28]. Furthermore, cholesterol, though not indispensable, plays a key role in their pore-forming mechanism [14,29,30,31,32,33,34], a mechanism still not fully understood, especially with regard to the sequence of events during pore formation and the final stoichiometry of the pore [35,36,37,38,39,40,41,42]. Overall, actinoporins represent a simple and optimal model to study the challenging biophysical transition from a water-soluble conformation to an integral transmembrane state.…”
Section: Pore-forming Proteins (Pfps)mentioning
confidence: 99%
“…However, actinoporins are very well studied from the structure-function point of view, allowing protein engineering to overcome these hurdles. Several research studies delve into the details of the protein-lipid interactions [10,15,30,31,33,42,99,100,101,102,103], making possible the application of different strategies directed to improve toxin specificity: for example, protecting the toxin region responsible for membrane binding or blocking the N-terminal domain directly implicated in pore formation. Actinoporins can be engineered to protect their key regions with polypeptide domains, which can later be released by tumor specific proteases.…”
Section: Biotechnological Applications Of Pfpsmentioning
confidence: 99%